Abstract
Hypoglycemia in newborns, despite beeing most common metabolic complication, is not exactly defined value. Universally adopted treshold of 2,5 mmol/l is without scientific justification.
Nevertheless it should be safe concerning long term neurodevelopment outcome. The treshold of 2,5 mmol/l is used as well in most guidelines throughout the world.
We are going to present most cited papers shortly. Hypoglycemia in newborns has a wide variety of non-specific symptoms and could be also completely asymptomatic.
These asymptomatic hypoglycemias may be overlooked even when using the most vigorous glucose sampling by bed-side tester. Continous glucose monitoring systems offer live and reliable insight to glucose homeostasis.
It does enhance our diagnostic and terapeutic possibilites in newborns at risk of hypoglycemia.